Notably, PRKN exhibited the highest alteration frequency, affecting 34% of all cancer samples, followed by OPTN (21%), PINK1 (18%), SRC (15%), BECN1 (13%), MAP1LC3A (9%), and BNIP3L (5%) (Figure 6a). The gene discussed is PRKN; the disease is cancer.